phase readout
saveNCT07170592: A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Bionoxx Inc.. Phase: PHASE1. Conditions: Treatment-Refractory Solid Tumors
view source ↗
comments(0)
5-min edit window · permanent after that